Bilaketaren emaitzak - Yu.E. Balykina
- Erakusten 1 - 20 emaitzak -- 32
- Hurrengo orria
-
1
Using indirect comparisons in pharmacoeconomic examination nork Yu. E. Balykina, A. S. Kolbin
Argitaratua 2015Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
2
TRIALS OF NEW ANTIBACTERIAL AGENTS - ANY PROSPECTS? nork A.S. Kolbin, S.V. Sidorenko, Yu.E. Balykina
Argitaratua 2010Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
3
TRIALS OF NEW ANTIBACTERIAL AGENTS - ANY PROSPECTS? nork A.S. Kolbin, S.V. Sidorenko, Yu.E. Balykina
Argitaratua 2010Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
4
Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital nork A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina
Argitaratua 2015Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
5
Pharmacoeconomic analysis of Flemoclav Solutab® use in adult patients with acute sinusitis in routine outpatient clinical practice in Russia nork A. S. Kolbin, I. A. Vilum, M. A. Proskurin, Yu. E. Balykina
Argitaratua 2018Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
6
PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD nork A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin
Argitaratua 2015Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
7
Health technology assessment of colorectal cancer chemotherapy with afl ibercept nork A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin
Argitaratua 2018Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
8
Pharmacoeconomic evaluation of ipragliflozin in combination with metformin in comparison with other regimens of therapy for type 2 diabetes mellitus nork A. S. Kolbin, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin
Argitaratua 2021Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
9
HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE nork A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina
Argitaratua 2016Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
10
Health technology assessment of hyaluronans in osteoarthritis treatment nork A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin
Argitaratua 2018Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
11
Pharmacoeconomic analysis of botulinum toxin in complex therapy for cerebral palsy nork A. S. Kolbin, I. A. Vilum, M. A. Proskurin, Yu. E. Balykina
Argitaratua 2018Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
12
Pharmacoeconomic analysis of vemurafenib and dabrafenib use in patients with inoperable or metastatic melanoma with BRAF V600 mutation nork A. S. Kolbin, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin
Argitaratua 2018Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
13
PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMP... nork A. S. Kolbin, I. A. Vilum, М. A. Proskurin, Yu. E. Balykina
Argitaratua 2017Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
14
Pharmacoeconomic analysis of the use of botulinum toxin in the treatment of poststroke spasticity nork A. S. Kolbin, I. A. Vilum, M. A. Proskurin, Yu. E. Balykina
Argitaratua 2018Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
15
BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD nork A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina
Argitaratua 2015Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
16
Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study nork A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina
Argitaratua 2023Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
17
Pharmacoeconomic analysis of the use of ibrutinib in therapy of the first line of a chronic lymphocytic leukaemia for patients with 17p deletion nork A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin
Argitaratua 2018Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
18
Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases nork A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina
Argitaratua 2018Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
19
Pharmacoeconomic evaluation of mirabegron: results of the healthcare budget impact analysis nork A. S. Kolbin, I. A. Vilium, M. A. Proskurin, Yu. E. Balykina
Argitaratua 2018Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua -
20
Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia nork I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina
Argitaratua 2018Sailkapena: Lanean...Connect to this object online.
Kokapena: Lanean...
Liburua